Citation Impact
Citing Papers
Functional and Effective Connectivity: A Review
2011 Standout
Effects of Psilocybin-Assisted Therapy on Major Depressive Disorder
2020 Standout
Psilocybin with psychological support for treatment-resistant depression: six-month follow-up
2017 Standout
Trial of Psilocybin versus Escitalopram for Depression
2021 Standout
Multi-target strategies for the improved treatment of depressive states: Conceptual foundations and neuronal substrates, drug discovery and therapeutic application
2006
Classic serotonergic psychedelics for mood and depressive symptoms: a meta-analysis of mood disorder patients and healthy participants
2021 Standout
The NMDA receptor glycine modulatory site: a therapeutic target for improving cognition and reducing negative symptoms in schizophrenia
2003
Functional neuroanatomy of auditory mismatch processing: an event-related fMRI study of duration-deviant oddballs
2003
Glutamate receptor ion channels
2005 Standout
RIM1α and Interacting Proteins Involved in Presynaptic Plasticity Mediate Prepulse Inhibition and Additional Behaviors Linked to Schizophrenia
2010 StandoutNobel
Glutamate Receptor Ion Channels: Structure, Regulation, and Function
2010 Standout
The free-energy principle: a rough guide to the brain?
2009 Standout
Frontal theta as a mechanism for cognitive control
2014 Standout
Lessons learned from the fate of AstraZeneca's drug pipeline: a five-dimensional framework
2014 Standout
Psychometric Evaluation of the Altered States of Consciousness Rating Scale (OAV)
2010
Mismatch negativity (MMN), the deviance-elicited auditory deflection, explained
2009 Standout
Converging Evidence of NMDA Receptor Hypofunction in the Pathophysiology of Schizophrenia
2003
Acute and chronic effects of ketamine upon human memory: a review
2006
Neural Synchrony in Brain Disorders: Relevance for Cognitive Dysfunctions and Pathophysiology
2006 Standout
Measurement of extensive auditory discrimination profiles using the mismatch negativity (MMN) of the auditory event-related potential (ERP)
2006
Convergence of biological and psychological perspectives on cognitive coordination in schizophrenia
2003
Mismatch negativity in schizophrenia: a family study
2003
Ligand-regulated oligomerization of β2-adrenoceptors in a model lipid bilayer
2009 StandoutNobel
The free-energy principle: a unified brain theory?
2010 Standout
Memory‐based or afferent processes in mismatch negativity (MMN): A review of the evidence
2005 Standout
Modulatory effect of the 5-HT1A agonist buspirone and the mixed non-hallucinogenic 5-HT1A/2A agonist ergotamine on psilocybin-induced psychedelic experience
2016
Network pharmacology: the next paradigm in drug discovery
2008 Standout
Psilocybin with psychological support for treatment-resistant depression: an open-label feasibility study
2016 Standout
Dysconnection in Schizophrenia: From Abnormal Synaptic Plasticity to Failures of Self-monitoring
2009
Nicotinic modulation of human auditory sensory memory: Evidence from mismatch negativity potentials
2005
Anti-NMDA-receptor encephalitis: case series and analysis of the effects of antibodies
2008 Standout
Psychedelics
2016 Standout
Identification of a serotonin/glutamate receptor complex implicated in psychosis
2008 Nature
Redox dysregulation, neurodevelopment, and schizophrenia
2009
From Revolution to Evolution: The Glutamate Hypothesis of Schizophrenia and its Implication for Treatment
2011
Neuroanatomical and Neurochemical Substrates of Timing
2010 Standout
Glutamate and Schizophrenia: Phencyclidine, N‐Methyl‐d‐Aspartate Receptors, and Dopamine–Glutamate Interactions
2007
22q11.21 Deletion Syndromes: A Review of Proximal, Central, and Distal Deletions and Their Associated Features
2015 Standout
Mismatch negativity in schizophrenia: a meta-analysis
2005
Repetition and the brain: neural models of stimulus-specific effects
2005 Standout
The paradoxical psychological effects of lysergic acid diethylamide (LSD)
2016
Autism-Associated Neuroligin-3 Mutations Commonly Disrupt Tonic Endocannabinoid Signaling
2013 StandoutNobel
Brain correlates of music-evoked emotions
2014 Standout
Neocortical excitation/inhibition balance in information processing and social dysfunction
2011 StandoutNature
Circuit-based framework for understanding neurotransmitter and risk gene interactions in schizophrenia
2008
Deviance-related electrophysiological activity in mice: is there mismatch negativity in mice?
2004
Mismatch negativity potentials and cognitive impairment in schizophrenia
2003
Rethinking schizophrenia
2010 StandoutNature
Mismatch negativity: clinical research and possible applications
2003
Mismatch Negativity Responses in Schizophrenia: A Combined fMRI and Whole-Head MEG Study
2004
Heritability and Reliability of P300, P50 and Duration Mismatch Negativity
2006
What we can do and what we cannot do with fMRI
2008 StandoutNature
NMDA Receptor Function, Neuroplasticity, and the Pathophysiology of Schizophrenia
2004
The neural basis of psychedelic action
2022 Standout
Serotonergic modulation of mismatch negativity
2005
Tripping on nothing: placebo psychedelics and contextual factors
2020 Standout
N1 and the mismatch negativity are spatiotemporally distinct ERP components: Disruption of immediate memory by auditory distraction can be related to N1
2007
The mismatch negativity (MMN) in basic research of central auditory processing: A review
2007 Standout
Progressive and Interrelated Functional and Structural Evidence of Post-Onset Brain Reduction in Schizophrenia
2007
Synaptic Plasticity: Multiple Forms, Functions, and Mechanisms
2007 Standout
COMT Val108/158Met Modifies Mismatch Negativity and Cognitive Function in 22q11 Deletion Syndrome
2005
Emotional responses to music: The need to consider underlying mechanisms
2008 Standout
Psilocybin links binocular rivalry switch rate to attention and subjective arousal levels in humans
2007
Glutamate and Schizophrenia: Beyond the Dopamine Hypothesis
2006
The mismatch negativity (MMN): towards the optimal paradigm
2003 Standout
Psilocybin – Summary of knowledge and new perspectives
2013
Effects of Lorazepam on the Neuromagnetic Mismatch Negativity (MMNm) and Auditory Evoked Field Component N100m
2004
Large-scale brain networks and psychopathology: a unifying triple network model
2011 Standout
NMDA receptor subunit diversity: impact on receptor properties, synaptic plasticity and disease
2013 Standout
Whatever next? Predictive brains, situated agents, and the future of cognitive science
2013 Standout
Music and Speech Listening Enhance the Recovery of Early Sensory Processing after Stroke
2009
Rapid and sustained symptom reduction following psilocybin treatment for anxiety and depression in patients with life-threatening cancer: a randomized controlled trial
2016 Standout
Effects of psilocybin on time perception and temporal control of behaviour in humans
2006
Abnormal neural oscillations and synchrony in schizophrenia
2010 Standout
Graded Visual Attention Modulates Brain Responses Evoked by Task-irrelevant Auditory Pitch Changes
2005
Acute, subacute and long-term subjective effects of psilocybin in healthy humans: a pooled analysis of experimental studies
2010
A theory of cortical responses
2005 Standout
The Computational Anatomy of Psychosis
2013
Cortical inhibitory neurons and schizophrenia
2005 Standout
Next Generation of Fluorine-Containing Pharmaceuticals, Compounds Currently in Phase II–III Clinical Trials of Major Pharmaceutical Companies: New Structural Trends and Therapeutic Areas
2016 Standout
Peak experiences and the afterglow phenomenon: When and how do therapeutic effects of hallucinogens depend on psychedelic experiences?
2015
Pavlovian conditioning–induced hallucinations result from overweighting of perceptual priors
2017 StandoutScience
Human hallucinogen research: guidelines for safety
2008
Psychedelic drugs: neurobiology and potential for treatment of psychiatric disorders
2020
Common circuit defect of excitatory-inhibitory balance in mouse models of autism
2009 StandoutNobel
Psilocybin produces substantial and sustained decreases in depression and anxiety in patients with life-threatening cancer: A randomized double-blind trial
2016 Standout
Differential contributions of serotonin receptors to the behavioral effects of indoleamine hallucinogens in mice
2010
Psilocybin-assisted treatment for alcohol dependence: A proof-of-concept study
2015 Standout
Do NMDA receptor antagonist models of schizophrenia predict the clinical efficacy of antipsychotic drugs?
2007
Using Psilocybin to Investigate the Relationship between Attention, Working Memory, and the Serotonin 1A and 2A Receptors
2005
Hallucinogens
2004 Standout
Works of R. Koller being referenced
Mismatch negativity predicts psychotic experiences induced by nmda receptor antagonist in healthy volunteers
2002
Effects of the 5-HT2A Agonist Psilocybin on Mismatch Negativity Generation and AX-Continuous Performance Task: Implications for the Neuropharmacology of Cognitive Deficits in Schizophrenia
2003
Ketamine-Induced Deficits in Auditory and Visual Context-Dependent Processing in Healthy Volunteers
2000
How specific are deficits in mismatch negativity generation to schizophrenia?
2003